Dementia care gap: US annual diagnoses projected to hit 1 million by 2060

American adults will face a doubled annual rate of new dementia diagnoses by 2060, according to projections cited in a recent study. The number of adults diagnosed each year is expected to rise from 514,000 in 2020 to 1 million in 2060. This increase will place additional pressure on a healthcare system that experts say is already struggling to meet current demand.

The rising incidence is driven by longer life expectancy and demographic changes. The Hispanic population in the United States nearly doubled between 2000 and 2024. The Alzheimer’s Association notes that Hispanic adults are 1.5 times as likely to develop dementia as white adults. Jordan Weiss, an assistant professor at the Optimal Aging Institute at NYU Langone, stated that even if individual risk factors are reduced, the sheer number of people entering older age brackets will increase the total caseload.

The workforce required to care for these patients is shrinking. A 2024 report by the American Health Care Association found that almost all nursing homes reported difficulty recruiting new staff. Two-thirds of facilities identified a lack of interested or qualified candidates as a primary issue. About half of the facilities reported limiting new resident admissions to manage capacity.

Financial constraints are compounding the staffing crisis. The median wage for nursing assistants at assisted living facilities and in home healthcare was less than $19 an hour in May 2025, according to the Bureau of Labor Statistics. The median wage for home health aides was $17 an hour. Regina Shih, a professor of epidemiology at Emory University, described the retention rate for direct care workers as very low, noting that the work is physically and emotionally demanding and cannot be replaced by artificial intelligence.

Government funding changes add another layer of complexity. The One Big Beautiful Bill Act, passed in 2025, included nearly $1 trillion in cuts to Medicaid spending over 10 years. KFF reports that Medicaid pays for more than half of the country’s long-term care spending. Shih called this a serious challenge for expanding access to services like home care and respite care for eligible patients.

Medical specialists are also in short supply. The number of geriatricians in the United States dropped from 10,270 in 2000 to 7,413 in 2022. Weiss attributed the decline partly to compensation issues and lower interest in the residency among medical students. States are responding with targeted incentives; in 2025, almost half reported offering payments to recruit or retain Medicaid home care workers, according to a KFF survey. South Carolina established a loan forgiveness program for physicians who complete geriatric fellowships and practice in the state for at least five years.

Recent FDA approvals for drugs like Kisunla and Leqembi offer modest slowing of cognitive decline for some patients with early Alzheimer’s disease. New blood tests for diagnosis and risk prediction have also been approved. Julie Zissimopoulos, a professor at the University of Southern California, noted that while these tools may improve lives, they will be costly for the healthcare system.